Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases
Identifieur interne : 000048 ( Main/Exploration ); précédent : 000047; suivant : 000049Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases
Auteurs : RBID : ISTEX:259_1996_Article_BF00834537.pdfEnglish descriptors
- KwdEn :
Abstract
Indium-111 pentetreotide scintigraphy was performed in two patients for the localization of recurrent medullary thyroid carcinoma treated by surgery and external radiotherapy 1 and 10 years earlier. A marked uptake of the radiopharmaceutical was demonstrated in the lung areas that had been irradiated. These cases strongly suggest that this uptake is related to pulmonary fibrosis, a well-known complication of radiotherapy, even long after the irradiation. Therefore, attention must be paid to the avoidance of false-positive interpretation of somatostatin receptor scintigraphy in patients previously treated by radiotherapy.
DOI: 10.1007/BF00834537
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title>Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases</title><author><name>Michel Stoffel</name><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, University of Louvain (UCL), Mont-Godinne, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Nuclear Medicine, University of Louvain (UCL), Mont-Godinne</wicri:regionArea><wicri:noRegion>Mont-Godinne</wicri:noRegion></affiliation></author><author><name>François Jamar</name><affiliation wicri:level="1"><mods:affiliation>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name>Julian Donckier</name><affiliation wicri:level="1"><mods:affiliation>Department of Internal Medicine, University of Louvain (UCL), Mont-Godinne, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, University of Louvain (UCL), Mont-Godinne</wicri:regionArea><wicri:noRegion>Mont-Godinne</wicri:noRegion></affiliation></author><author><name>Philippe Hainaut</name><affiliation wicri:level="1"><mods:affiliation>Department of Internal Medicine, University of Louvain (UCL), Brussels, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, University of Louvain (UCL), Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name>Patrick Decoster</name><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, University of Louvain (UCL), Mont-Godinne, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Nuclear Medicine, University of Louvain (UCL), Mont-Godinne</wicri:regionArea><wicri:noRegion>Mont-Godinne</wicri:noRegion></affiliation></author><author><name>Christian Beckers</name><affiliation wicri:level="1"><mods:affiliation>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name>Stanislas Pauwels</name><affiliation wicri:level="1"><mods:affiliation>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels, Belgium</mods:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="RBID">ISTEX:259_1996_Article_BF00834537.pdf</idno><date when="1996">1996</date><idno type="doi">10.1007/BF00834537</idno><idno type="wicri:Area/Main/Corpus">000C37</idno><idno type="wicri:Area/Main/Curation">000C37</idno><idno type="wicri:Area/Main/Exploration">000048</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Indium-111 pentetreotide</term><term>Medullary thyroid carcinoma</term><term>Radiation fibrosis</term><term>Radiotherapy</term><term>Somatostatin receptor scintigraphy</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">Indium-111 pentetreotide scintigraphy was performed in two patients for the localization of recurrent medullary thyroid carcinoma treated by surgery and external radiotherapy 1 and 10 years earlier. A marked uptake of the radiopharmaceutical was demonstrated in the lung areas that had been irradiated. These cases strongly suggest that this uptake is related to pulmonary fibrosis, a well-known complication of radiotherapy, even long after the irradiation. Therefore, attention must be paid to the avoidance of false-positive interpretation of somatostatin receptor scintigraphy in patients previously treated by radiotherapy.</div></front></TEI><mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="d85cefc75e92649292ed5eccf64b944afb5be4a8"><titleInfo lang="eng"><title>Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases</title></titleInfo><name type="personal"><namePart type="given">Michel</namePart><namePart type="family">Stoffel</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Nuclear Medicine, University of Louvain (UCL), Mont-Godinne, Belgium</affiliation></name><name type="personal"><namePart type="given">François</namePart><namePart type="family">Jamar</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels, Belgium</affiliation></name><name type="personal"><namePart type="given">Julian</namePart><namePart type="family">Donckier</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Internal Medicine, University of Louvain (UCL), Mont-Godinne, Belgium</affiliation></name><name type="personal"><namePart type="given">Philippe</namePart><namePart type="family">Hainaut</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Internal Medicine, University of Louvain (UCL), Brussels, Belgium</affiliation></name><name type="personal"><namePart type="given">Patrick</namePart><namePart type="family">Decoster</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Nuclear Medicine, University of Louvain (UCL), Mont-Godinne, Belgium</affiliation></name><name type="personal"><namePart type="given">Christian</namePart><namePart type="family">Beckers</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels, Belgium</affiliation></name><name type="personal"><namePart type="given">Stanislas</namePart><namePart type="family">Pauwels</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Centre of Nuclear Medicine, University of Louvain (UCL), Brussels, Belgium</affiliation></name><typeOfResource>text</typeOfResource><genre>Case Report</genre><genre>Original Paper</genre><originInfo><publisher>Springer-Verlag, Berlin/Heidelberg</publisher><dateCreated encoding="w3cdtf">1995-11-25</dateCreated><dateValid encoding="w3cdtf">2004-11-17</dateValid><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="eng">Indium-111 pentetreotide scintigraphy was performed in two patients for the localization of recurrent medullary thyroid carcinoma treated by surgery and external radiotherapy 1 and 10 years earlier. A marked uptake of the radiopharmaceutical was demonstrated in the lung areas that had been irradiated. These cases strongly suggest that this uptake is related to pulmonary fibrosis, a well-known complication of radiotherapy, even long after the irradiation. Therefore, attention must be paid to the avoidance of false-positive interpretation of somatostatin receptor scintigraphy in patients previously treated by radiotherapy.</abstract><subject lang="eng"><genre>Key words</genre><topic>Medullary thyroid carcinoma</topic><topic>Somatostatin receptor scintigraphy</topic><topic>Indium-111 pentetreotide</topic><topic>Radiotherapy</topic><topic>Radiation fibrosis</topic></subject><relatedItem type="series"><titleInfo type="abbreviated"><title>Eur J Nucl Med</title></titleInfo><titleInfo><title>European Journal of Nuclear Medicine</title><partNumber>Year: 1996</partNumber><partNumber>Volume: 23</partNumber><partNumber>Number: 6</partNumber></titleInfo><genre>Archive Journal</genre><originInfo><dateIssued encoding="w3cdtf">1996-06-01</dateIssued><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><subject usage="primary"><topic>Medicine & Public Health</topic><topic>Imaging / Radiology</topic><topic>Nuclear Medicine</topic></subject><identifier type="issn">0340-6997</identifier><identifier type="issn">Electronic: 1619-7089</identifier><identifier type="matrixNumber">259</identifier><identifier type="local">IssueArticleCount: 23</identifier><recordInfo><recordOrigin>Springer-Verlag, 1996</recordOrigin></recordInfo></relatedItem><identifier type="doi">10.1007/BF00834537</identifier><identifier type="matrixNumber">Art17</identifier><identifier type="local">BF00834537</identifier><accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition><accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition><accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition><accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition><accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition><accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition><part><extent unit="pages"><start>723</start><end>726</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 1996</recordOrigin><recordIdentifier>259_1996_Article_BF00834537.pdf</recordIdentifier></recordInfo></mods></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000048 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000048 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:259_1996_Article_BF00834537.pdf
|texte= Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases
}}
| This area was generated with Dilib version V0.5.81. |  |